These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 10702938

  • 1. [Carcinoma-associated retinopathy: a review with clinical examples].
    Sobottka B, Schlote T, Besch D, Djelebova T, Wilhelm H, Zrenner E.
    Klin Monbl Augenheilkd; 2000 Jan; 216(1):17-24. PubMed ID: 10702938
    [Abstract] [Full Text] [Related]

  • 2. [Paraneoplastic retinopathy in 2 patients with breast carcinoma].
    Huober J, Holz FG, Schmid H, Nölle B, Bellmann C, Krastel H, Wallwiener D, Bastert G.
    Zentralbl Gynakol; 1997 Jan; 119(6):278-81. PubMed ID: 9312964
    [Abstract] [Full Text] [Related]

  • 3. Role of anti-recoverin autoantibodies in cancer-associated retinopathy.
    Adamus G, Guy J, Schmied JL, Arendt A, Hargrave PA.
    Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2626-33. PubMed ID: 7688357
    [Abstract] [Full Text] [Related]

  • 4. Recoverin and Hsc 70 are found as autoantigens in patients with cancer-associated retinopathy.
    Ohguro H, Ogawa K, Nakagawa T.
    Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):82-9. PubMed ID: 9888430
    [Abstract] [Full Text] [Related]

  • 5. Clinical and immunologic aspects of cancer-associated retinopathy.
    Ohguro H, Yokoi Y, Ohguro I, Mamiya K, Ishikawa F, Yamazaki H, Metoki T, Takano Y, Ito T, Nakazawa M.
    Am J Ophthalmol; 2004 Jun; 137(6):1117-9. PubMed ID: 15183799
    [Abstract] [Full Text] [Related]

  • 6. The cancer-associated retinopathy antigen is a recoverin-like protein.
    Thirkill CE, Tait RC, Tyler NK, Roth AM, Keltner JL.
    Invest Ophthalmol Vis Sci; 1992 Sep; 33(10):2768-72. PubMed ID: 1388144
    [Abstract] [Full Text] [Related]

  • 7. Retinal dysfunction in cancer-associated retinopathy is improved by Ca(2+) antagonist administration and dark adaptation.
    Ohguro H, Ogawa K, Maeda T, Maruyama I, Maeda A, Takano Y, Nakazawa M.
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2589-95. PubMed ID: 11581204
    [Abstract] [Full Text] [Related]

  • 8. Antibodies to recoverin induce apoptosis of photoreceptor and bipolar cells in vivo.
    Adamus G, Machnicki M, Elerding H, Sugden B, Blocker YS, Fox DA.
    J Autoimmun; 1998 Oct; 11(5):523-33. PubMed ID: 9802939
    [Abstract] [Full Text] [Related]

  • 9. [Paraneoplastic retinopathy and anti-recoverin antibodies].
    Bataller L, Graus F, Dalmau J.
    Neurologia; 2002 Mar; 17(3):156. PubMed ID: 11927105
    [No Abstract] [Full Text] [Related]

  • 10. Cancer-associated retinopathy induced by both anti-recoverin and anti-hsc70 antibodies in vivo.
    Ohguro H, Ogawa K, Maeda T, Maeda A, Maruyama I.
    Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3160-7. PubMed ID: 10586938
    [Abstract] [Full Text] [Related]

  • 11. Paraneoplastic retinopathy: a novel autoantibody reaction associated with small-cell lung carcinoma.
    Murphy MA, Thirkill CE, Hart WM.
    J Neuroophthalmol; 1997 Jun; 17(2):77-83. PubMed ID: 9176775
    [Abstract] [Full Text] [Related]

  • 12. Mechanisms of photoreceptor cell death in cancer-associated retinopathy.
    Maeda T, Maeda A, Maruyama I, Ogawa KI, Kuroki Y, Sahara H, Sato N, Ohguro H.
    Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):705-12. PubMed ID: 11222531
    [Abstract] [Full Text] [Related]

  • 13. Aberrant expression of photoreceptor-specific calcium-binding protein (recoverin) in cancer cell lines.
    Maeda A, Ohguro H, Maeda T, Wada I, Sato N, Kuroki Y, Nakagawa T.
    Cancer Res; 2000 Apr 01; 60(7):1914-20. PubMed ID: 10766180
    [Abstract] [Full Text] [Related]

  • 14. Cancer associated retinopathy (CAR): An autoimmune-mediated paraneoplastic syndrome.
    Khan N, Huang JJ, Foster CS.
    Semin Ophthalmol; 2006 Apr 01; 21(3):135-41. PubMed ID: 16912011
    [Abstract] [Full Text] [Related]

  • 15. [Paraneoplastic retinal degeneration, cancer-associated retinopathy].
    Kuriyama M, Fujii A, Yoneda M.
    Ryoikibetsu Shokogun Shirizu; 2000 Apr 01; (29 Pt 4):347-50. PubMed ID: 11031966
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Human melanoma-associated retinopathy (MAR) antibodies alter the retinal ON-response of the monkey ERG in vivo.
    Lei B, Bush RA, Milam AH, Sieving PA.
    Invest Ophthalmol Vis Sci; 2000 Jan 01; 41(1):262-6. PubMed ID: 10634629
    [Abstract] [Full Text] [Related]

  • 18. Antibody reactions with retina and cancer-associated antigens in 10 patients with cancer-associated retinopathy.
    Thirkill CE, Keltner JL, Tyler NK, Roth AM.
    Arch Ophthalmol; 1993 Jul 01; 111(7):931-7. PubMed ID: 8392327
    [Abstract] [Full Text] [Related]

  • 19. Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies.
    Weleber RG, Watzke RC, Shults WT, Trzupek KM, Heckenlively JR, Egan RA, Adamus G.
    Am J Ophthalmol; 2005 May 01; 139(5):780-94. PubMed ID: 15860281
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.